The production of αβ T cells in the thymus involves multiple steps. First, progenitor cells termed ‘thymocytes’ that do not express CD4 and CD8 differentiate to become CD4+CD8+ double-positive (DP) cells. These cells then mature to give rise to CD4 and CD4 single-positive (SP) populations. The CD4/CD8 lineage decision is known to be influenced by multiple factors, including Tcra locus rearrangement, TCR signalling and positive selection. Now, Tessa Crompton and co-workers report that this process involves the pioneer transcription factors Foxa1 and Foxa2. They first show that both Foxa1 and Foxa2 are expressed in thymocytes and are required for T-cell development. Specifically, conditional deletion of Foxa1 and Foxa2 from developing DP thymocytes leads to reduced numbers of SP cells and reduced SP cell maturation. The researchers further show that Foxa1/2 conditional deletion causes significant changes in the expression of RNA splicing-related genes. In line with this, they identify >850 differentially used exons in Foxa1/2-deficient thymocytes. These exons occur within genes that are known to regulate T-cell development as well as within genes associated with RNA splicing. Together, these and other findings suggest that Foxa1 and Foxa2 contribute to thymocyte positive selection by regulating the splicing of genes essential for T-cell development, but that they also exert widespread control over alternative splicing.
OutFOXing T-cell development
OutFOXing T-cell development. Development 1 August 2021; 148 (15): e148_e1503. doi:
Download citation file:
Advertisement
Cited by
Call for papers: Uncovering Developmental Diversity
Development invites you to submit your latest research to our upcoming special issue: Uncovering Developmental Diversity. This issue will be coordinated by our academic Editor Cassandra Extavour (Harvard University, USA) alongside two Guest Editors: Liam Dolan (Gregor Mendel Institute of Molecular Plant Biology, Austria) and Karen Sears (University of California Los Angeles, USA).
Choose Development in 2024
In this Editorial, Development Editor-in-Chief James Briscoe and Executive Editor Katherine Brown explain how you support your community by publishing in Development and how the journal champions serious science, community connections and progressive publishing.
Journal Meeting: From Stem Cells to Human Development
Register now for the 2024 Development Journal Meeting From Stem Cells to Human Development. Early-bird registration deadline: 3 May. Abstract submission deadline: 21 June.
Pluripotency of a founding field: rebranding developmental biology
This collaborative Perspective, the result of a workshop held in 2023, proposes a set of community actions to increase the visibility of the developmental biology field. The authors make recommendations for new funding streams, frameworks for collaborations and mechanisms by which members of the community can promote themselves and their research.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.